Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-4838
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model ; volume:24 ; number:1 ; day:27 ; month:9 ; year:2012 ; pages:115-127 ; date:1.2013
Journal of materials science / Materials in medicine ; 24, Heft 1 (27.9.2012), 115-127, 1.2013
- Creator
-
Lewis, Andrew L.
Holden, Rachel R.
Chung, S. Ting
Czuczman, Peter
Kuchel, Timothy
Finnie, John
Porter, Susan
Foster, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10856-012-4768-2
- URN
-
urn:nbn:de:101:1-2019062722403168677654
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lewis, Andrew L.
- Holden, Rachel R.
- Chung, S. Ting
- Czuczman, Peter
- Kuchel, Timothy
- Finnie, John
- Porter, Susan
- Foster, David
- SpringerLink (Online service)
Other Objects (12)
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials